Dipeptide diaminobutyroyl benzylamide diacetate
Is Dipeptide diaminobutyroyl benzylamide diacetate safe?
No published safety study
DNo meaningful dataCosmetic ingredientas of 2026-10-26
As a cosmetic ingredient, it has been on the market for about two decades. No reports of harm to the whole body have been published. That fits a peptide that stays mostly in the outer skin. Irritation and contact reactions are the real risks with any leave-on peptide product. No long-term safety study exists, and cosmetic rules do not require one. 12
Read the full Dipeptide diaminobutyroyl benzylamide diacetate page
More on Dipeptide diaminobutyroyl benzylamide diacetate
Citations
- Happi 2005: Pentapharm introduces anti-wrinkle active (Syn-Ake) happi.com
- CosmeticsDesign Europe 2007: snake venom-based anti-ageing cream launched in UK cosmeticsdesign-europe.com
- Zhu 2026, International Journal of Cosmetic Science: ex vivo and clinical studies of a serum combining dipeptide diaminobutyroyl benzylamide diacetate, acetyl hexapeptide-8 and other actives doi.org
- DSM 2020: Syn-Ake product brochure with supplier in vivo test dsm.com
Reference information only, not medical advice. Drawn from the Dipeptide diaminobutyroyl benzylamide diacetate article, fact-checked against the cited sources. No dosing anywhere on this site.